Physicochemical Properties
| Molecular Formula | C24H31CL2N3O3 |
| Molecular Weight | 480.43 |
| Exact Mass | 479.174 |
| Elemental Analysis | C, 60.00; H, 6.50; Cl, 14.76; N, 8.75; O, 9.99 |
| CAS # | 55974-42-0 |
| Related CAS # | ARC 239; 67339-62-2 |
| PubChem CID | 10345075 |
| Appearance | White to off-white solid powder |
| LogP | 4.322 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 32 |
| Complexity | 629 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | Cl.Cl.O=C1C(C)(C)C2C=CC=CC=2C(N1CCN1CCN(C2C=CC=CC=2OC)CC1)=O |
| InChi Key | SAJKHRHHDGSJEZ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H29N3O3.2ClH/c1-24(2)19-9-5-4-8-18(19)22(28)27(23(24)29)17-14-25-12-15-26(16-13-25)20-10-6-7-11-21(20)30-3;;/h4-11H,12-17H2,1-3H3;2*1H |
| Chemical Name | 2-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-4,4-dimethylisoquinoline-1,3-dione;dihydrochloride |
| Synonyms | ARC239 2HCl; ARC 239 2HCl; ARC-239 2HCl; ARC239 dihydrochloride; ARC-239 dihydrochloride; ARC 239 dihydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | 5-HT1A receptor; Alpha-2B adrenergic receptor |
| References |
[1]. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa. Auton Autacoid Pharmacol. 2003 Aug;23(4):208-19. |
Solubility Data
| Solubility (In Vitro) | DMSO: ~125 mg/mL (~260.2 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.33 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.33 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (4.33 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0815 mL | 10.4073 mL | 20.8147 mL | |
| 5 mM | 0.4163 mL | 2.0815 mL | 4.1629 mL | |
| 10 mM | 0.2081 mL | 1.0407 mL | 2.0815 mL |